Suppr超能文献

呼气气流受限与端坐呼吸相关,在左心衰竭中可通过血管扩张剂和利尿剂逆转。

Expiratory flow limitation is associated with orthopnea and reversed by vasodilators and diuretics in left heart failure.

作者信息

Boni E, Bezzi M, Carminati L, Corda L, Grassi V, Tantucci Claudio

机构信息

Department of Internal Medicine, Respiratory Medicine, University of Brescia, Italy.

出版信息

Chest. 2005 Aug;128(2):1050-7. doi: 10.1378/chest.128.2.1050.

Abstract

BACKGROUND

In patients with acute left heart failure (LHF), orthopnea has also been related to the occurrence or worsening of expiratory flow limitation (EFL) in the supine position. We wished to assess whether short-term treatment with vasodilators and diuretics was able to abolish supine EFL and whether this could help to control orthopnea in patients with acute LHF.

METHODS

In nine nonobese (ie, mean [+/- SD] body mass index, 24 +/- 5 kg/m2), never-smoker patients (two men and seven women; mean age, 77 +/- 7 years) with acute LHF (mean ejection fraction, 43 +/- 15%), we assessed EFL by the negative expiratory pressure method and dyspnea by the Borg scale, with patients in both the seated and supine positions, before and after short-term treatment with vasodilators and diuretics until hospital discharge. Orthopnea was defined as a positive difference in the Borg score between measurements made with the patient in the supine and seated positions. Postural variations in the end-expiratory lung volume were inferred from changes in inspiratory capacity (IC) that were measured under the same circumstances.

RESULTS

Before treatment, with the patient in the seated position the mean dyspnea score was 1.5 +/- 0.5, the mean IC was 1.49 +/- 0.38 L, seven patients were non-flow-limited, and two patients were flow-limited. During recumbency, the mean dyspnea score was 2.7 +/- 0.5 (p < 0.01 vs seated position values), the mean IC was 1.66 +/- 0.45 L, and seven patients exhibited EFL. After a mean duration of 17 +/- 8 days of treatment (range, 7 to 28 days), EFL was detected in two patients only in the supine position, IC increased both in the seated position (1.65 +/- 0.34 L; p < 0.01) and the supine position (1.81 +/- 0.41 L; p = 0.07) position, and, although only two patients denied orthopnea, the mean dyspnea score during recumbency actually decreased to 1.9 +/- 1.0 (p < 0.05).

CONCLUSIONS

Our results indicate that short-term treatment with vasodilators and diuretics is able to control orthopnea and to remove supine EFL in most patients with acute LHF, suggesting a posture-related increase in bronchial obstruction as the main mechanism of EFL, which appears to play a role in the occurrence and severity of orthopnea in these circumstances.

摘要

背景

在急性左心衰竭(LHF)患者中,端坐呼吸也与仰卧位呼气流量受限(EFL)的发生或加重有关。我们希望评估血管扩张剂和利尿剂的短期治疗是否能够消除仰卧位EFL,以及这是否有助于控制急性LHF患者的端坐呼吸。

方法

在9名非肥胖(即平均[±标准差]体重指数,24±5kg/m²)、从不吸烟的急性LHF患者(2名男性和7名女性;平均年龄,77±7岁)(平均射血分数,43±15%)中,我们通过负呼气压力法评估EFL,并通过Borg量表评估呼吸困难,患者分别处于坐位和仰卧位,在使用血管扩张剂和利尿剂进行短期治疗直至出院前后进行评估。端坐呼吸定义为患者仰卧位和坐位测量的Borg评分之间的正差值。呼气末肺容积的体位变化通过在相同情况下测量的吸气容量(IC)变化推断得出。

结果

治疗前,患者坐位时平均呼吸困难评分为1.5±0.5,平均IC为1.49±0.38L,7名患者无流量受限,2名患者有流量受限。卧位时,平均呼吸困难评分为2.7±0.5(与坐位值相比,p<;0.01),平均IC为1.66±0.45L,7名患者出现EFL。经过平均17±8天(范围,7至28天)的治疗后,仅在两名仰卧位患者中检测到EFL,坐位(1.65±0.34L;p<;0.01)和仰卧位(1.81±0.41L;p = 0.07)的IC均增加,并且,尽管只有两名患者否认有端坐呼吸,但卧位时的平均呼吸困难评分实际上降至1.9±1.0(p<;0.05)。

结论

我们的结果表明,血管扩张剂和利尿剂的短期治疗能够控制大多数急性LHF患者的端坐呼吸并消除仰卧位EFL,提示支气管阻塞与体位相关的增加是EFL的主要机制,这似乎在这些情况下端坐呼吸的发生和严重程度中起作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验